Stay updated on Rapastinel Adjunct in Depression Clinical Trial
Sign up to get notified when there's something new on the Rapastinel Adjunct in Depression Clinical Trial page.

Latest updates to the Rapastinel Adjunct in Depression Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.8.1 instead of v3.8.0.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe record provides details for the completed Phase 3 RAP-MD-02 study of rapastinel as an adjunctive treatment for major depressive disorder, including its participant criteria, study arms, outcomes, and protocol documents.SummaryDifference70%

- Check22 days agoChange DetectedThe displayed site revision changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner announces that NIH content may use “Super Intelligence” in place of “Artificial Intelligence” during a terminology transition.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check43 days agoChange DetectedThe footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to Rapastinel Adjunct in Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rapastinel Adjunct in Depression Clinical Trial page.